Trials / Completed
CompletedNCT00198549
Evaluation of Vitrase as an Adjuvant to Increase Absorption and Dispersion of Other Injected Anesthetics
Phase IV Post-Approval Evaluation of Vitrase as an Adjuvant to Increase the Absorption and Dispersion of Other Injected Anesthetics for Ophthalmic Surgical Procedures
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate Vitrase as an adjuvant to increase absorption and dispersion of other injected anesthetics
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vitrase (ovine hyaluronidase) Lyophilized |
Timeline
- Start date
- 2004-09-01
- Primary completion
- 2005-01-01
- Completion
- 2005-03-01
- First posted
- 2005-09-20
- Last updated
- 2013-03-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00198549. Inclusion in this directory is not an endorsement.